Heart failure with preserved ejection fraction (HFpEF) is a common clinical syndrome
associated with high rates of morbidity and mortality. Due to the lack of evidence-based …

Background Recent studies have suggested that a higher body mass index (BMI) is
associated with an improved prognosis in heart failure (HF). Adropin is a recently identified …

Obesity and heart failure are two of the leading causes of morbidity and mortality in the
world. The relationship between obesity and cardiovascular diseases is complex and not …

The prevalence of heart failure (HF) is skyrocketing worldwide, and is closely associated
with serious morbidity and mortality. In particular, HF is one of the main causes for the …

Background Amino (N)–terminal pro–brain natriuretic peptide (NT-proBNP) testing is useful
for diagnostic and prognostic evaluation in patients with dyspnea. An inverse relationship …

BACKGROUND: The prevalence of left ventricular hypertrophy (LVH), coronary artery
disease, and subclinical cardiomyopathy in diabetic patients without known cardiac disease …

BACKGROUND: B-Type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are
frequently used in diagnosing and monitoring patients with heart failure. Recent studies …

Heart failure (HF) is a leading cause of mortality in the western world. Despite advances in
the treatment of HF, like the use of angiotensin-converting enzyme (ACE) inhibitors, β …

Obesity has reached epidemic proportions in the general population and is associated with
an increased risk for the development of new-onset heart failure (HF). However, in acute and …

Obesity is a problem reaching epidemic proportions in westernized society and is a major
cause of preventable death. 1 Obesity has many adverse effects on coronary artery disease …